Tod Nestor
Analyst · H.C. Wainwright. Please proceed with your question
Thank you, James. Net sales for the full year 2019 were $12.7 million compared with $18.1 million in 2018, a year-over-year decrease of 29.8%. This decrease was driven by lower sales of our military globe LED light fixture and intelligent product lines and was mostly due to a one-time large order in 2018 as well as a decrease in sales of our commercial products reflecting fluctuations in the timing, pace and size of projects in that market. 2019's full year net loss was $7.4 million or $0.60 loss per basic diluted share, compared with a full year loss of $9.1 million, or $0.76 loss per base diluted share in 2018. However, most importantly, and very relevantly, we believe it is important for investors to look closely at the steady and meaningful improvements we made from the second through fourth quarters of 2019 to reinvigorate sales, reduce costs and create a substantial platform for growth and improve financial results in the future, while mitigating the bottom line losses experienced in 2019 in total. Sales for the fourth quarter of 2019, were $3.5 million compared with 2018 fourth quarter sales of $3.1 million, an increase of 13.2% year-over-year. When compared to $2.9 million in the third quarter of 2019, sales were up 21.7% on a sequential basis. The sequential increases can be attributed primarily to traction we're gaining from the introduction of new products, an increase in our direct sales team, a shift in our sales mix, which was weighted more heavily towards to the commercial market, the timing of military sales, which had been delayed from prior quarters due to budgetary constraints with Defense Logistics Agency, and an increased value proposition, primarily from our commercial products. These increases were partially offset by decline in sales to a major Northeast Ohio Hospital System. From a mix perspective, in the fourth quarter military sales were $1.5 million, representing approximately 42.5% of total sales for the fourth quarter of 2019, compared to $1.9 million or 61% of total sales for the fourth quarter of 2018 and $1.2 million or 40.5% of total sales for the third quarter of 2019. The sequential increase in the percentage mix of military sale as a percentage of our total sales quarter-on-quarter is primarily due to the timing of military sale, which has been delayed in the third quarter due to budgetary constraints at the DLA. The year-over-year decrease was driven primarily by reduced sales to one large distributor to the navy. Sales to commercial customers were $2 million, representing approximately 57.5% of total sales for the fourth quarter of 2019 compared to $1.2 million, or 38.3% of total sales for the fourth quarter of 2018 and $1.7 million or 59% of total sales for the third quarter of 2019. The increase in dollar sales was mainly due to new sales to several school districts and colleges as well as increases in sales of our RedCap product. Gross profit for the fourth quarter of 2019 was $950,000 compared with $19,000 in year ago quarter, a significant increase mainly driven by unfavorable access and obsolete and related reserve adjustments in the fourth quarter of 2018 of $590,000. On a sequential basis, gross profit was roughly flat compared to $1 million in the third quarter of 2019. As a percentage of revenue gross profit margin was 27.1% in the fourth quarter of 2019, compared to 0.6% in the fourth quarter of 2018 and 35.3% in the third quarter of 2019. However, when adjusting gross profit margins for excess and obsolete and related reserves, our actual gross profit margins become 29.3% for the fourth quarter of 2019, compared to 18.2% in the fourth quarter of 2018, and 23.6% in the fourth -- the third quarter of 2019. The sequential decrease in gross profit margin was a result of fluctuations in our excess and obsolete reserves which we experienced from quarter-to-quarter. Moving forward, we expect our normalized gross margins to be in the mid-20s in the near term and begin to approach the low-30% range as we introduce new products and make further improvements to our supply chain. However, depending on the sales mix and inventory valuations, we may see some fluctuations from quarter-to-quarter. Operating expenses in the fourth quarter of 2019 were $2.1 million compared to $3 million in the year ago quarter, a decrease of $865,000 or 29% year-over-year, which is driven by both lower product development and selling general and administrative expenses and the inclusion of restructuring expenses in the fourth quarter of 2018. Taking those one by one, product development expenses decreased by 408,000 year-over-year to $249,000 in the fourth quarter of 2019, as a result of lower salaries and related benefits, driven by a lower headcount, which resulted from office closures in San Jose and Taiwan in the first half of 2019, and lower outside testing fees. SG&A expense decreased 15% to $1.9 million in the fourth quarter of 2019, compared to $2.2 million in the year ago quarter. The decrease was a direct result of our directed efforts to streamline our operations and create an agile infrastructure to support sustainable long-term growth. Key drivers of the decrease were lower salaries, including stock-based compensation and related benefits, and lower headcount resulting from office closures in San Jose in Taiwan in the first half of 2019, which were partially offset by an increase in recruitment and legal costs. Sequentially operating expenses increased 14.3% compared to $1.9 million in the third quarter of 2019. This increase was primarily driven by an increase in salaries and related benefits and increased legal and recruitment costs. As James said, most of the new headcount we added in the fourth quarter of 2019 were related to sales driven activities and we consider all hires made as an investment in our future growth. Loss from operations during the fourth quarter of 2019 was $1.2 million an improvement of $1.8 million compared to a loss from operations of $3 million in the fourth quarter of 2018. Sequentially this compares to a loss of operations of $833,000 in the third quarter of 2019. The sequential increase in the loss was due primarily to lower gross margins resulting from inventory valuations and an increased investment in sales-driven SG&A salaries and related benefit costs. As James mentioned, we encourage investors and analysts to look at directional and longer term trends of our business and the actions we are taking to accelerate growth and narrow our losses, along a trajectory that will ultimately return us towards sustainable profitability. Net loss for the fourth quarter of 2019 improved to $1.3 million, or $0.11 loss per basic and diluted share compared with a loss of $3 million or $0.25 loss per basic and diluted share in the year ago quarter, and a net loss of $946,000 or an 8% [ph] (sic $0.08) loss per share in the third quarter of 2019. Now I would like to turn to the balance sheet. As of December 31, 2019, we had cash and cash equivalents of $350,000 compared to $6.3 million at the end of 2018 and roughly in line with $634,000 of cash and cash equivalents at the end of the third quarter of 2019. We continue to maintain a low yet acceptable minimum cash balance from working capital and other short term needs as part of our financial strategy to optimize the deployment of cash and reduce borrowing costs as much as possible. As we have said in the past, we no longer employ the practice of dressing up the balance sheet to be adding cash and debt but leaving net debt unchanged on the balance sheet that used to be used in the past. Total debt as of December 31, 2019, included short term credit line borrowings of $715,000 and convertible notes outstanding of $2.6 million, total debt balance of $3.3 million or net debt of $3 million. This compares to $2.2 million in total debt as of December 31, 2018, which was comprised solely of credit line borrowings, while $6.3 million of cash [ph] on the balance for a negative net debt balance. Starting now and moving forward, we would like to introduce you to a metric we view as very important and that is a metric we call total availability. We determine total availability at any point in time by taking the cash on hand plus any excess borrowing capability we have on a short-term borrowing facility. Effectively, this is a measurement of our access to cash at any given point in time, and is much more relevant metric than simply looking at a cash balance. As of December 31, 2019, we had a total availability of $2 million, which consisted of $400,000 of cash and $1.6 million of additional borrowing availability on a credit facility. Also, as of September 30, 2019, we had a total availability of $1.3 million, which consisted of $600,000 of cash and $700,000 of additional borrowing availability on our credit facility. We intend to continue to communicate this metric to you in future earnings releases and filings. Also, as James mentioned during the fourth quarter, we raised additional capital of $1.1 million in net proceeds through the issuance of a single note to a single lender, and subsequently subsequent to year-end we raised additional capital through a private placement of 3.4 million shares of our common stock and an aftermarket purchase price of $0.799 per share, and unregistered warrants to purchase up to 3.4 million shares of common stock at an exercise price of $0.674 per share for gross proceeds of $2.7 million, and net proceeds after expenses of $2.4 million, and finally $2.1 million after a mandatory debt repayment on a note to a single lender loan in the first quarter. Proceeds from these offering will provide short-term funding for our operations and initiatives for growth. We continue to analyze our cash needs considering sales prospects, current operations, and our plans for continual improvement. It is our current view that we may need additional external financing during 2020. We expect to explore and consider a variety of financing sources given the timing of when an need may arise and market conditions at the time. Our operating cash burn for the fourth quarter slowed to $464,000, largely driven by very effective working capital management. Accounts receivable were $2.3 million at the end of 2019, compared to $2.2 million at the end of 2018, a modest decline of $136,000 reflecting the decline in sales, as well as continued effective collection of accounts receivable. Inventories declined to $6.2 million as of December 31, 2019, compared to $8.1 million at the end of 2018. The decrease was due to low procurement in the first half of 2019 as a result of purchasing fee implemented by the current management team. During the second half of 2019, we also negotiated cost reduction terms with suppliers on certain products and introduced the price investment strategy on products we have an excess inventory, which resulted in net reduction of our gross inventory levels and excess inventory reserves of $1.9 million, compared to 2018. Please bear in mind that as we launch new products and deplete popular products inventory we will begin purchasing more inventory late in the fourth quarter of 2019 and in the first quarter of this year. Accounts payable declined significantly to $1.3 million as of December 31, 2019, down from $3.6 million as of the end of 2018, which reflects the large build up in inventory during 2018 and the need to pay suppliers for those goods during 2019. One other significant change to the balance sheet between 2018 and 2019 is the increase in current assets resulting from adoption and new changes from period-to-period you see on the earnings release are because of the adoption of the new standard for lease accounting. And finally, I wanted to update you on tariffs. Tariffs continue to be manageable for Energy Focus with no material impact on our business, with only about $140,000 for the entirety of 2019. In fact, recently, we've been able to eliminate 25% tariffs on electronic components charged towards the end of 2019 by sourcing some alternate suppliers in 2020. Also we continue to work with our vendors on price reductions to mitigate the need to increase prices and are also evaluating alternative sourcing locations and choices if necessary. Currently, we have no need to pass along a minimum level of tariffs we've incurred from the products we source out of China at this time, but we'll continue to monitor the situation and we'll respond accordingly. Finally, the recent U.S.-Chinese settlement, deferred planned tariffs that would have impacted some of our products and so was a favorable outcome. Our other potential meaningful liability remains manageable and non-material and that is our warranty liability. The combination of very low failure rates of our tubes and replacement tube and a replacement tube was identified for an existing customer which allowed us to continue to experience minimal costs or warranties and still be able to afford to offer very valuable 10 year and 5 year warranties to our customers. Lastly, as James mentioned, to-date, we have not experienced any significant disruption in either supply chain or sales due to Coronavirus pandemic. However, we've had to make some significant adjustments in our supply chain to ensure we continue to receive products in a timely and affordable fashion and we readily acknowledge that this is much too early to assess how the Coronavirus will impact our sales as we move forward. This is a very dynamic and changing world we currently live in, and our plans will have to be real time and we will respond appropriately. With that we would like to open the call for questions.